https://www.plantadoce.com/empresa/alta-life-sciences-engorda-en-el-ano-del-covid-19-el-fondo-de-altamar-invierte-veinte-millones.html
Accure Therapeutics appoints Dr. Rossella Medori as chief medical officer
https://accure.health/accure-therapeutics-appoints-dr-rossella-medori-as-chief-medical-officer/
Alta Life Sciences leads an oversubscribed investment round into Inbiomotion to launch its diagnostic product in breast cancer
• The financing round is led by Alta Life Sciences Spain I FCR, a vehicle managed by Altamar Private Equity SGIIC. Existing investors including Institut Català de Finances (ICF) have also participated in the financing. • Inbiomotion is in advanced stage of development of a single gene-based test for predicting response to bisphosphonates in breast cancer adjuvant setting and prevent metastasis. • The capital increase is intended to complete regulatory…
Accure Therapeutics strengthens scientific advisory board by appointing top-class scientists
Five neurology experts join CNS specialist’s scientific advisory board to support clinical trial development of disease modifying drug candidates Barcelona, Spain, January 11, 2021 – Accure Therapeutics, a private translational R&D engine at clinical stage in the Central Nervous System (CNS) field, today announces the appointment of five world-class neurology experts to its scientific advisory board. They will help boost innovation and advocate for Accure Therapeutics, as the company drives…
Peptomyc Board of Directors appoints Giacomo Di Nepi as Chairman of the Board
Peptomyc Board of Directors appoints Giacomo Di Nepi as Chairman of the Board
Sanifit to Participate in the 2021 ICR Conference
Sanifit to Participate in the 2021 ICR Conference
Peptomyc steps forward as a Clinical Stage Biotech company
Peptomyc steps forward as a Clinical Stage Biotech company
Binx health receives EUA authorizing At-Home COVID-19 sample collection by universities and employers
binx health receives EUA authorizing At-Home COVID-19 sample collection by universities and employers
SANIFIT – Subgroup Analyses from Sanifit’s CaLIPSO Phase 2b Clinical Study Published in Kidney International Reports
Subgroup Analyses from Sanifit’s CaLIPSO Phase 2b Clinical Study Published in Kidney International Reports
Peptomyc announces a new equity financing round of 11.4M€
This investment will help Peptomyc lead its drug candidate OMO103 into clinical phase I/II as a treatment for solid tumors Barcelona, Spain, December 15, 2020 – Peptomyc S.L., a biotech company specialized in the development of protein and peptide therapeutics for cancer treatment, has just announced the completion of an equity financing round of EUR 11.4 million. The company is focused on the development of a new generation of cell penetrating…